Quantum Research and Valuation have worked with Arterial since 2013 providing in-depth research, financial analysis and valuation. Arterial’s approach to asset selection and the global strength of their team and their scientific, industry and financial expertise is outstanding. It is a pleasure to be associated with a firm that sets standards to which others should aspire to.



I first met the Arterial team when they entered into negotiations with our company to explore the opportunity on investing in the company’s Biotechnology IP. We found their approach to funding for life science, their professionalism and the global reputation of their team and their determination to see a business succeed was so refreshing in comparison to numerous other VC’s we had previously approached. We have no hesitation in recommending other life science companies to work with the Arterial management team who we know will enthusiastically pursue a successful outcome.

Dr. DOUGLAS REES PhD MRSNZ – Founder, Director & CSO, AQIX Ltd


I have worked with Arterial since shortly after their launch, reviewing prospective investee companies for EIS compatibility and handling all EIS matters from initial HMRC advance assurance through to submission of forms EIS1. I am delighted to work with Arterial, and proud to be able to consider my firm to be one of their professional counterparties.

CHRISTOPHER LEE – Managing Director, Fiscability UK Limited, Former Inspector of Taxes & Senior Tax Partner, James Cowper LLP


Our firm has recommended Arterial to a number of clients. We have been very impressed with the high levels of due diligence and corporate governance which we have found to be leagues above any other UK EIS offering that we have advised upon. Arterial are an exceptional firm and we will continue to recommend them to our clients.

JAMES FERGUSON DipFA – Director of Enness Wealth, Independent Financial Adviser